CLAIM #2922 · Abbott Laboratories (ABT) · 2022Q3 earnings call · Oct 18, 2022 · due Dec 31, 2022
“In September, we began production of several Similac products, which we expect will begin to reach retail store shelves over the coming weeks.”
Robert Ford · CEO
CANNOT_DETERMINE
versus commitment · official band 5 percent
Committed
we expect will begin to reach retail store shelves over the coming weeks
Reported
we've been able to increase production of our non-WIC brands with a focus on serving the broader infant formula market and building back inventory levels on retail shelves
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2022Q3 earnings call.